Apellis Pharmaceuticals
Apellis Pharmaceuticals is a biotechnology research company developing drug delivery technologies and therapeutics for the treatment of chronic inflammatory diseases.
1
Funding Rounds
$6.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ce**** Fr****** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ce**** Fr****** | - | - | |
| Ge**** Ch** | - | - | linkedin twitter instagram |
| Al** Ma****** | - | - | |
| Pa** Fo****** | - | - | |
| St******* O'***** | - | - |
Funding series
Funding Series Analysis
The company Apellis Pharmaceuticals has raised a total of $6m in funding over 1 rounds.
Key Insights:
- Apellis Pharmaceuticals funding round, August 2013: $6m
Apellis Pharmaceuticals funding round, August 2013
$6m
Industries
Apellis Pharmaceuticals is active in the following industries:
- Biomedical engineering
- Biopharmaceutical
- Engineering
- Amyotrophic lateral sclerosis
- Technology
- Biotechnology
- Biology
- Synthetic chemistry
- Healthcare
- Industrial Biotechnology